Department of Psychological Sciences, University of Missouri, 210 McAlester Hall, 320 S. 6th Street, Columbia, MO 65211, USA.
Department of Psychological Sciences, University of Missouri, 210 McAlester Hall, 320 S. 6th Street, Columbia, MO 65211, USA.
Drug Alcohol Depend. 2024 Feb 1;255:111084. doi: 10.1016/j.drugalcdep.2024.111084. Epub 2024 Jan 9.
Only a small proportion of individuals who initiate nonmedical use of prescription opioids (NUPO) transition to heroin, suggesting that more nuanced aspects of NUPO may be better indicators of risk for escalating opioid use trajectories. This study leveraged panel data to identify NUPO typologies based on NUPO characteristics associated with opioid risk trajectories (route of administration, motives) and compared rates of heroin initiation at follow-up across typologies.
Latent class analyses were run among respondents with no history of heroin use from the Monitoring the Future Panel Study (base year N=10,408) at modal ages 18, 19/20, 21/22, 23/24, and 25/26. Indicators included oral NUPO, nonoral NUPO, and NUPO motives to experiment, have a good time with friends, get high, escape problems, manage pain, relax, and sleep. Heroin initiation at follow-ups through modal age 29/30 was predicted from class membership.
No NUPO, self-medication (oral, manage pain), recreational (oral, nonoral, experiment, get high, have a good time with friends), and mixed-motive (all routes, all motives) classes emerged. Heroin initiation rates did not differ across no NUPO and self-medication classes; recreational and mixed-motives classes initiated heroin at higher rates than the other classes and comparable rates to each other. Non-NUPO drug use prior to heroin initiation was prevalent in recreational and mixed-motive classes.
NUPO does not uniformly or uniquely increase risk for heroin initiation. Leveraging more nuanced indicators of risk for heroin use and targeting polysubstance use in addition to opioid-specific programming may enhance the efficacy of public health efforts.
只有一小部分开始非医疗用途使用处方类阿片(NUPO)的个体过渡到使用海洛因,这表明 NUPO 的更多细微方面可能是更好的提示风险的指标,可以用来预测阿片类药物使用轨迹的升级。本研究利用面板数据,根据与阿片类药物风险轨迹(给药途径、动机)相关的 NUPO 特征,确定 NUPO 类型,并比较不同类型在随访中开始使用海洛因的比率。
在没有海洛因使用史的监测未来面板研究(基础年 N=10408)的受访者中,利用潜在类别分析在模态年龄 18、19/20、21/22、23/24 和 25/26 岁时进行。指标包括口服 NUPO、非口服 NUPO 和 NUPO 尝试、与朋友同乐、兴奋、逃避问题、止痛、放松和睡眠的动机。通过模态年龄 29/30 随访时开始使用海洛因的情况,由类别成员预测。
未出现 NUPO、自我用药(口服、止痛)、娱乐(口服、非口服、尝试、兴奋、与朋友同乐)和混合动机(所有途径、所有动机)的类别。无 NUPO 和自我用药类别之间的海洛因起始率没有差异;娱乐和混合动机类别开始使用海洛因的比率高于其他类别,且彼此之间的比率相当。在开始使用海洛因之前,娱乐和混合动机类别中存在非 NUPO 药物使用的情况。
NUPO 并不统一或独特地增加使用海洛因的风险。利用更细微的海洛因使用风险指标,并针对除阿片类药物外的多物质使用进行干预,可能会提高公共卫生工作的效果。